|By Marketwired .||
|May 1, 2014 05:00 AM EDT||
SAN DIEGO, CA -- (Marketwired) -- 05/01/14 -- Ivera Medical Corporation, headquartered in San Diego, CA, announced that the United States District Court for the Southern District of California has rendered summary judgment against some Ivera patents, in motions filed by Excelsior Medical, Hospira, and Catheter Connections. The case involves U.S. Patent Nos. 7,780,794 ("the '794 patent"), 7,985,302 ("the '302 patent"), and 8,206,514 ("the '514 patent").
"We are disappointed in the Court's decision and are evaluating our options, including an appeal of this decision, and note that these patents continue through an inter partes review process within the US Patent and Trademark office," said Bob Rogers, CEO of Ivera Medical. "Our strategy regarding intellectual property has always been to build a robust portfolio, so that an adverse ruling in one case does not impact the broader strategy. Indeed, Ivera continues to be very pleased with our progress in a Florida court patent infringement case, and the impending issuance of what will be the seminal patent in this space, for which we have an exclusive license. Further it is important to note that Ivera has freedom to operate with our Curos® Port Protectors."
Curos products employ passive disinfection to disinfect intravenous devices eliminating the technique variation found in manual procedures. With two disinfecting port protector options -- Curos Strips and individual Curos -- nurses can conveniently comply with valve disinfection protocols by simply peeling the foil seal from the distinctive green cap and twisting Curos onto the top of any luer-activated IV access port or needleless valve. Inside Curos, a 70% isopropyl alcohol (IPA) saturated sponge-like foam bathes the surface of the venous access device to provide consistent and reliable disinfection of the port surface in three minutes. Once in place, Curos maintains a clean port for up to seven days, if not removed. Extending passive disinfection and protection to male-luer connectors, Curos Tips improve disinfection compliance with IV tubing connectors and needleless syringes by immersing the exterior of the male luer in alcohol. Curos Tips come in a convenient strip dispenser that places five disinfecting Tips in easy reach of clinicians at the point of care. The cap's highly visible bright green color allows auditors to monitor caregiver disinfection practice compliance at a glance.
About Ivera Medical
Ivera Medical Corporation, a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at www.curos.com
Vice President, Business Development
Ivera Medical Corp.
In today's uber-connected, consumer-centric, cloud-enabled, insights-driven, multi-device, global world, the focus of solutions has shifted from the product that is sold to the person who is buying the product or service. Enterprises have rebranded their business around the consumers of their products. The buyer is the person and the focus is not on the offering. The person is connected through multiple devices, wearables, at home, on the road, and in multiple locations, sometimes simultaneously...
Aug. 24, 2016 09:45 AM EDT Reads: 2,233
Fact: storage performance problems have only gotten more complicated, as applications not only have become largely virtualized, but also have moved to cloud-based infrastructures. Storage performance in virtualized environments isn’t just about IOPS anymore. Instead, you need to guarantee performance for individual VMs, helping applications maintain performance as the number of VMs continues to go up in real time. In his session at Cloud Expo, Dhiraj Sehgal, Product and Marketing at Tintri, wil...
Aug. 24, 2016 09:45 AM EDT Reads: 408
Aug. 24, 2016 09:36 AM EDT
Aug. 24, 2016 09:00 AM EDT Reads: 3,489
Aug. 24, 2016 08:59 AM EDT Reads: 177
Aug. 24, 2016 08:00 AM EDT Reads: 3,807
Aug. 24, 2016 08:00 AM EDT Reads: 1,807
Aug. 24, 2016 07:45 AM EDT Reads: 2,049
Aug. 24, 2016 07:15 AM EDT Reads: 1,646
Aug. 24, 2016 07:15 AM EDT Reads: 1,779
Aug. 24, 2016 07:00 AM EDT Reads: 1,728
Aug. 24, 2016 05:00 AM EDT Reads: 2,055
Aug. 24, 2016 04:30 AM EDT Reads: 2,164
Aug. 24, 2016 03:30 AM EDT Reads: 2,908
Akana has announced the availability of version 8 of its API Management solution. The Akana Platform provides an end-to-end API Management solution for designing, implementing, securing, managing, monitoring, and publishing APIs. It is available as a SaaS platform, on-premises, and as a hybrid deployment. Version 8 introduces a lot of new functionality, all aimed at offering customers the richest API Management capabilities in a way that is easier than ever for API and app developers to use.
Aug. 24, 2016 02:00 AM EDT Reads: 1,395